Nomura Holdings’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,182
Closed -$1.67M 1989
2024
Q4
$1.67M Buy
+20,182
New +$1.59M ﹤0.01% 1214
2024
Q1
Sell
-18,790
Closed -$1M 1780
2023
Q4
$1M Sell
18,790
-38,845
-67% -$1.89M ﹤0.01% 1178
2023
Q3
$2.86M Buy
57,635
+53,635
+1,341% +$3M 0.01% 701
2023
Q2
$238K Sell
4,000
-26,167
-87% -$1.49M ﹤0.01% 1146
2023
Q1
$1.71M Buy
+30,167
New +$1.93M 0.01% 862
2021
Q2
Sell
-12,000
Closed -$740K 2135
2021
Q1
$740K Buy
+12,000
New +$760K ﹤0.01% 1212
2015
Q3
Sell
-11,200
Closed -$287K 1751
2015
Q2
$287K Buy
+11,200
New +$284K ﹤0.01% 1473
2013
Q3
Sell
-31,665
Closed -$535K 2429
2013
Q2
$535K Buy
+31,665
New +$489K ﹤0.01% 1273

Other funds holding GMED

Nomura Holdings's GMED Position: Q1 2025 in Review

Nomura Holdings sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 20,182 shares — an estimated $1.67M sold.

Nomura Holdings first reported a position in GMED in Q2 2013 and held it in 8 quarters. The position peaked at $2.86M in Q3 2023. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Nomura Holdings reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Nomura Holdings sold 20,182 Globus Medical shares in Q1 2025, an estimated $1.67M.
  • Nomura Holdings first reported a position in Globus Medical in Q2 2013 and held it in 8 quarters.
  • Nomura Holdings's Globus Medical position peaked at $2.86M in Q3 2023.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.